Cargando…

Is a third SARS‐CoV‐2 vaccine dose efficient in allogeneic haematopoietic cell transplant recipients?

When and how often should allogeneic haematopoietic cell transplantation recipients be vaccinated against severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) is unclear. The report by Bankova et al. suggests that a third SARS‐CoV‐2 vaccine dose is important but still insufficient in some pa...

Descripción completa

Detalles Bibliográficos
Autor principal: Spyridonidis, Alexandros
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878174/
https://www.ncbi.nlm.nih.gov/pubmed/36477621
http://dx.doi.org/10.1111/bjh.18591